Geron
CA - Foster CityBiotechnology
Focus: Geron is a clinical-stage oncology-focused biotech company headquartered in Foster City, CA, developing small-molecule telomerase inhibitors for hematologic malignancies and solid tumors. The company has one marketed product (RYTELO/imetelstat sodium) and an active pipeline spanning 20+ clinical trials.
Profile data last refreshed 53m ago · AI intelligence enriched 3w ago
Open Jobs
7
Should You Work at Geron?
AI assessmentGeron offers oncology specialists and leaders a rare blend of approved-product stability and early-pipeline optionality, but requires comfort with opaque company financials and early-stage clinical risk.
Why Work Here
- One approved product (RYTELO, launched in growth phase with LOE not until 2039) provides revenue stability while pipeline matures.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Growth12.6yr
Sole approved product and revenue driver; telomerase inhibitor with long exclusivity runway (15+ years) in rare blood cancer.
Help build intelligence for Geron
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.